Retraction Note to: miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells

. 2021 May 10;21:255. doi: 10.1186/s12935-021-01958-0

PMCID: PMC8108323 PMID: 33971879

Retraction to: Cancer Cell Int (2017) 17:36 https://doi.org/10.1186/s12935-017-0407-9

The Editors-in-Chief have retracted this article [1]. Concerns were raised regarding a number of figures, specifically:

Figure 3a: the first and third panel for C33A appear to partially overlap.
Figure 3b: panel 2 for C33A appears to partially overlap with panel 2 for C33A in Figure 7b.
Figure 7a: panel 1 for HeLa appears to overlap with panel 3 for HeLa in Figure 7b.
Figure 7a: panel 3 for C33A appears to partially overlap with panels 4 and 4 for C33A in Figure 7b: panel 6 for HeLa appears to partially overlap with panel 5 for C33A.

The Editors-in-Chief therefore no longer have confidence in the reliability of the data reported in the article.

All authors agree to this retraction.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

1.Hu Y, Xie H, Liu Y, Liu W, Liu M, Tang H. miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells. Cancer Cell Int. 2017;17:36. doi: 10.1186/s12935-017-0407-9. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]